WuXi Biologics
Offering End-to-End Solutions
We currently operate 2 drug product facilities capable of producing liquid or lyophilized bioconjugates, cytotoxic compounds and other small molecule products at varying clinical and commercial scales. For details on each DP facility, click the corresponding tabs below.
Filling line capabilities:
Vial Size | Lyo Capacity (Full Load Quantity) | |
5 sqm | 20 sqm | |
2R | 21,696 | 84,975 |
6R | 11,316 | 44,957 |
10R | 9,678 | 37,026 |
20R | 6,300 | 23,463 |
50R | 3,300 | 13,299 |
Filling line capabilities:
Vial Size | Lyo Capacity (Full Load Quantity) | |
5 sqm | 20 sqm | |
2R | 22,736 | 81,950 |
6R | 11,613 | 43,956 |
10R | 10,101 | 37,026 |
20R | 6,405 | 23,463 |
50R | 3,542 | 12,980 |
WuXi XDC Packaging Center offers flexible layouts and both manual and automated solutions for a wide range of inspection, secondary and tertiary packaging. The state-of-the-art inspection, labeling and packaging equipment could support clients’both clinical and commercial supply locally and globally. With such facility as integral part of two DP manufacturing facilities at Wuxi new district site, we can streamline the DP inspection, labeling and packaging process, allowing quality products delivery to clients and patients safer and quicker.
This facility offers following service:
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?